SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-21-000740
Filing Date
2021-06-02
Accepted
2021-06-01 18:46:42
Documents
10
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K medicure6k.htm 6-K 13177
2 NOTICE OF MEETING ex991.htm EX-99.1 8772
3 MANAGEMENT INFORMATION CIRCULAR ex992.htm EX-99.2 245768
4 FORM OF PROXY ex993.htm EX-99.3 1160
5 GRAPHIC ex993_1.jpg GRAPHIC 566418
6 GRAPHIC ex993_2.jpg GRAPHIC 389228
7 GRAPHIC ex992_20.jpg GRAPHIC 523668
8 GRAPHIC ex992_21.jpg GRAPHIC 84102
9 GRAPHIC ex992_22.jpg GRAPHIC 291748
10 GRAPHIC ex992_23.jpg GRAPHIC 229629
  Complete submission text file 0001279569-21-000740.txt   3141918
Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31995 | Film No.: 21987000
SIC: 2834 Pharmaceutical Preparations